Introduction:
The demand for typhoid vaccines has been steadily increasing in China, driven by a growing awareness of the importance of vaccination in preventing the spread of infectious diseases. In 2026, China is expected to be a key player in the global typhoid vaccine market, with several leading producers dominating the industry. According to recent market research, the typhoid vaccine market in China is projected to grow at a CAGR of 8.5% from 2021 to 2026.
Top 10 Typhoid Vaccine Producers in China 2026:
1. Sinovac Biotech
Sinovac Biotech is a leading Chinese biopharmaceutical company that specializes in the research, development, production, and marketing of vaccines. With a production volume of over 10 million doses of typhoid vaccine annually, Sinovac Biotech is a major player in the Chinese market.
2. Shanghai Institute of Biological Products
The Shanghai Institute of Biological Products is a state-owned enterprise that produces a wide range of vaccines, including typhoid vaccines. With a market share of 15%, the institute is one of the top producers of typhoid vaccines in China.
3. Beijing Tiantan Biological Products
Beijing Tiantan Biological Products is another key player in the Chinese typhoid vaccine market, with a production volume of 8 million doses annually. The company has a strong presence in the market, catering to both domestic and international demand.
4. Wuhan Institute of Biological Products
Wuhan Institute of Biological Products is a leading vaccine manufacturer in China, producing over 5 million doses of typhoid vaccine each year. The institute has a reputation for high-quality vaccines and plays a crucial role in meeting the growing demand for typhoid vaccines in China.
5. Changchun Institute of Biological Products
Changchun Institute of Biological Products is a state-owned enterprise that produces a variety of vaccines, including typhoid vaccines. With a market share of 10%, the institute is a significant player in the Chinese typhoid vaccine market.
6. Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.
Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. is a private pharmaceutical company that specializes in the production of vaccines. The company produces over 3 million doses of typhoid vaccine annually and has been expanding its market presence in China.
7. Liaoning Chengda Biotechnology Co., Ltd.
Liaoning Chengda Biotechnology Co., Ltd. is a biotechnology company that focuses on the research and development of vaccines. The company has emerged as a key player in the Chinese typhoid vaccine market, with a production volume of 2 million doses annually.
8. Shenzhen Kangtai Biological Products Co., Ltd.
Shenzhen Kangtai Biological Products Co., Ltd. is a leading vaccine manufacturer in China, producing a wide range of vaccines, including typhoid vaccines. With a market share of 8%, the company is a significant player in the Chinese market.
9. Hualan Biological Engineering Inc.
Hualan Biological Engineering Inc. is a biopharmaceutical company that specializes in the production of vaccines. The company produces over 1.5 million doses of typhoid vaccine annually and has been expanding its market presence in China.
10. Walvax Biotechnology Co., Ltd.
Walvax Biotechnology Co., Ltd. is a biotechnology company that focuses on the research and development of vaccines. The company produces over 1 million doses of typhoid vaccine annually and has been gaining recognition in the Chinese market.
Insights:
The Chinese typhoid vaccine market is expected to continue its growth trajectory in the coming years, driven by increasing government initiatives to promote vaccination and prevent infectious diseases. With a projected CAGR of 8.5% from 2021 to 2026, the market is poised for significant expansion. As the top 10 typhoid vaccine producers in China continue to innovate and expand their production capacities, the country is likely to solidify its position as a key player in the global typhoid vaccine market. Additionally, collaborations between Chinese vaccine manufacturers and international organizations are expected to further boost the production and distribution of typhoid vaccines in China.
Related Analysis: View Previous Industry Report
